Watch CBS News

Moderna Files For Emergency Use Authorization Of Its COVID Vaccine In Teens After Study Shows 100% Effectiveness

CAMBRIDGE (CBS) -- Moderna on Thursday announced it has filed for emergency use authorization of its COVID vaccine in adolescents 12 to 17 years old. This comes after a study showed its vaccine was 100% effective in teenagers.

"We are pleased to announce that we have submitted for an emergency use authorization for our COVID-19 vaccine with the FDA for use in adolescents in the United States," said Moderna CEO Stéphane Bancel in a statement. "We are encouraged that the Moderna COVID-19 vaccine was highly effective at preventing COVID-19 and SARS-CoV-2 infection in adolescents."

Not a single teen who received two doses of the vaccine came down with the coronavirus, the Cambridge-based biotech company said in late May. In addition, there were "no significant safety concerns identified," and side effects were similar to those seen in adults.

Pfizer's two-dose vaccine has already been authorized for use in everyone 12 years old and above. Both Moderna and Pfizer have begun testing the vaccines in children as young as 6 months old.

Children are less likely to get seriously ill from the coronavirus, but they are representing a higher percentage of cases as more adults get vaccinated.

The Centers for Disease Control is urging parents to get their teens vaccinated as hospitalizations among young people increase.

View CBS News In
CBS News App Open
Chrome Safari Continue
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.